Introduction
Branchio-oto-renal (BOR) syndrome (MIM#113650) is an autosomal dominant disorder that is associated with branchial fistulae or cysts, preauricular pits, ear malformations, hearing impairment, and renal anomalies (1) . The incidence of BOR syndrome is approximately 1:40,000 (2) . Mutations in the EYA1 gene, the human homologue of the Drosophila eyes absent gene, have been shown to cause BOR syndrome (3, 4) . The EYA1 gene consists of 16 exons spanning 156 kb on chromosome 8q13.3 (5) . The EYA1 gene is a member of the EYA family, which is characterized by a divergent N-terminal activation domain and a conserved C-terminal Eya domain, and the gene functions as a transcriptional co-activator in the Eya-Six regulatory network for early development of different organs, including the ear and kidney (3) . Over 202 different mutations in the EYA1 gene that cause disease have been found in various populations (http://www.hgmd.cf.ac.uk/, last updated December 2017). However, few mutations have been identified in the Chinese population (6) . Reported here is a de novo mutation of the EYA1 gene first identified in a Chinese child with BOR syndrome.
Subjects and Methods

Patient
A girl was admitted to a local hospital in 2010 because of her short stature at age 3. Proteinuria (2+) and abnormal renal function (BUN 17.2 mmol/L, creatinine level 140 umol/L) were noted by the local hospital, and renal ultrasound indicated that the left kidney was 24.4 mm × 18.9 mm in size while the right kidney was 55.4 mm × 23.0 mm in size. In March 2011, the girl was referred to this facility for evaluation because of the continuing deterioration of renal function at age 4.6. She underwent surgery to remove a branchial cleft cyst at age 1.1 and surgery to repair pre-auricular fistulae at age 4.
On admission, a clinical examination revealed scars from surgery to repair fistulae in the preauricular region and surgery to remove a branchial cleft cyst in the neck ( Figures 1A and 1B The family's medical history was also investigated. Informed consent was obtained from the parents. Ethical approval to conduct this study was obtained from the Ethics Committee of the Children's Hospital of Fudan University.
Methods
In 2011, genomic DNA was extracted and purified from peripheral leukocytes in whole-blood samples using a DNA isolation kit (Qiagen, Hilden, Germany). All exons of the EYA1 gene were amplified using a polymerase chain reaction (PCR). Primers for the EYA1 gene were designed based on previously published information regarding intron-exon boundaries. The PCR product was purified with a QIA Quick PCR Purification Kit (Qiagen, Hilden, Germany). The purified product was cycle-sequenced with Big-Dye terminators (Applied Biosystems, Foster City, CA, USA), and the cycle sequence product was analyzed with an automated sequencer (ABI Prism 310 Genetic Analyzer). Novel mutations in EYA1 were investigated in 100 healthy controls using direct sequencing. Mutation nomenclature was based on the EYA1 cDNA sequence of NM_000503.3 (http://www.ncbi.nlm.nih.gov).
Results and Discussion
The patient's parents had no consanguinity, and there was no family history of branchial cleft cyst, preauricular fistulae, renal disease, or hearing loss. A novel deletion mutation, c.1381delA, was detected in the EYA1 gene, and the patient was heterozygous for this change (Figure 2A ). This deletion causes a frameshift of amino acids and results in a truncated protein 43 in South Korea and Japan (Table 1) (10, (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . In contrast, few mutations have been reported before in patients with BOR syndrome in Taiwan, China (Table  1) (7). All of these mutations were scattered through the EYA1 coding region; complex mutations involving chromosomal rearrangements have not been found in Asians.
Recent studies have found that mutations in both the SIX1 and SIX5 genes are also associated with BOR syndrome (19) . SIX1, the human homologue of the Drosophila sine oculis gene, encodes a DNA-binding protein associated with EYA1 (19, 30) . Most mutations identified in SIX1 are missense mutations, but small deletions have also been reported in patients with BOR syndrome (30) . SIX1 plays a role in EYA-SIX-PAX interaction in the development of the ears, kidneys, and other organs (31) . Evaluation of SIX1 and its related target genes may provide clues to the mechanisms involved in causing BOR syndrome (13) . The role of SIX5 in BOR is less clear. Although a few missense mutations in SIX5 have been reported in patients with BOR syndrome, the role of SIX5 variants in the pathophysiology of BOR has been questioned (13, 19) .
In conclusion, this case report has described a Chinese child with BOR syndrome and it has identified a novel frameshift mutation caused by a single basepair deletion in the EYA1 gene. The novel c.1381delA mutation is a disease-causing mutation, and this finding expands the spectrum of mutations in the EYA1 gene.
(p.R461fs467X). An analysis of mutations in the EYA1 gene in the family revealed that her parents did not carry the c.1381delA mutation. The mutation was not found in controls.
The patient was diagnosed with BOR syndrome based on clinical features and genetic testing. The patient subsequently received peritoneal dialysis. She was switched to hemodialysis in 2015 due to the loss of peritoneal function, and she received a kidney transplant in 2016. She was assessed at this facility every three to six months. The renal allograft is functioning normally.
BOR syndrome is characterized by a wide spectrum of clinical manifestations that represents a combination of branchial, otic, and renal anomalies (7) . Individuals with branchio-otic (BO) syndrome (OMIM#602588) are affected by the same branchial and otic anomalies as in BOR without the associated renal anomalies (8) . Due to the wide spectrum of phenotypic findings and the phenotypic variability between and within families, phenotypic criteria for clinical diagnosis of BOR syndrome have been proposed (9) . The major criteria include branchial anomalies, deafness, preauricular pits, and renal anomalies, while minor criteria include external, middle, and inner ear anomalies and preauricular tags. A definitive diagnosis is based on meeting ≥ 3 major criteria, meeting 2 major criteria and ≥ 2 minor criteria, or meeting 1 major criterion and having a first-degree relative with BOR syndrome. The patient in this study met 3 major criteria, i.e. branchial, preauricular, and renal anomalies. The most common manifestation of BOR is hearing loss, which can be conductive, sensorineural, or mixed (10) . Some studies estimate that BO/BOR has a prevalence of 2% amongst profoundly deaf children (2) . However, the current patient has no hearing loss.
BOR is genetically heterogeneous, although mutations in EYA1 are most commonly identified and segregate with the BOR phenotype in about 40% of families (9) . Causative variants include point mutations as well as large and small deletions (11) (12) (13) . EYA1 encodes a transcriptional regulator, and mice heterozygous for the targeted deletion of this gene have renal abnormalities and a conductive hearing loss similar to the human phenotype (14) . EYA1 homozygous null mice lack ears and kidneys (15) .
The current patient has a heterozygous deletion mutation (c.1381delA), which causes a frameshift of amino acids and results in a truncated protein (p.R461fs467X). This mutation is novel, and was not detected in controls. Thus, c.1381delA was deemed to be a disease-causing mutation. Over 202 different mutations in the EYA1 gene that cause disease have been found in various populations (http://www.hgmd. cf.ac.uk/, last updated December 2017), but most have been identified in subjects of European ancestry. More than 21 different mutations in the EYA1 gene have been identified in patients with BOR/BO syndrome
